This brand name is authorized in Lithuania, Poland.
The drug ABREA contains one active pharmaceutical ingredient (API):
1
|
UNII
R16CO5Y76E - ASPIRIN
|
|
Acetylsalicylic acid combines significant advantages such as strong anti-pyretic, analgesic and anti-inflammatory action, that is the measure of comparison with all the newer NSAIDs. |
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| B01AC06 | Acetylsalicylic acid | B Blood and blood forming organs → B01 Antithrombotic agents → B01A Antithrombotic agents → B01AC Platelet aggregation inhibitors excl. heparin |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| LT | Valstybinė vaistų kontrolės tarnyba | 1079508, 1079509, 1079510, 1082012, 1082013, 1082014, 1082015, 1082016, 1082017, 1082018, 1082019, 1082020, 1082021, 1082022, 1082023, 1082024, 1082025, 1082026, 1082027, 1082028, 1082029, 1082030, 1082031, 1082032, 1082033 |
| PL | Rejestru Produktów Leczniczych | 100364986, 100364992, 100365000 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.